Cure My Disease

Don't miss your cure!

 Log in / Sign up

Measuring hidden energy needs: a clue to better nutrition for gut failure patients

NCT ID NCT07714499

Knowledge-focused Sponsor: Institute of Oncology Ljubljana Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 20, 2026 · Last updated Jul 21, 2026 · Updated 1 time

Summary

This study measures how many calories people burn at rest, comparing healthy adults to those with intestinal failure (a condition where the gut cannot absorb enough nutrients). Researchers will also look at body composition and inflammation markers. The goal is to find out if energy needs differ based on gut function, which could lead to more personalized nutrition plans for patients.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could help tailor calorie and nutrition plans for people with intestinal failure, potentially improving their health outcomes.
What could go wrong
This is an observational comparison, not a treatment trial, so it won't directly test a new therapy. Results may not apply to all patients with intestinal failure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 92 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2025

Expected to finish

Oct 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Group A - Healthy Controls: * Age 18 to 65 years * No diagnosed chronic diseases * No hospitalization within the previous 30 days * No acute illness within the previous 14 days Group B - Participants With Intestinal Failure: * Age 18 to 65 years * Diagnostically confirmed intestinal failure * Stable clinical condition Exclusion Criteria: * Uncontrolled hyperthyroidism or hypothyroidism * Diabetes mellitus with poor glycemic control * Adrenal gland disease * Active inflammatory bowel disease, including Crohn's disease or ulcerative colitis * Celiac disease * Chronic pancreatitis * Active gastric or esophageal disease * Irritable bowel syndrome with significant symptoms * History of major abdominal surgery that permanently affects gastrointestinal function, except in participants with intestinal failure when this forms part of the condition under study * Heart failure * Active ischemic heart disease or recent myocardial infarction * Chronic obstructive pulmonary disease * Respiratory failure or need for long-term oxygen therapy * Progressive neurodegenerative disease * Dementia impairing the ability to participate * Severe stroke with significant functional impairment * Active tuberculosis * HIV/AIDS with clinically significant immunosuppression * Active systemic autoimmune disease * Active malignant disease * Advanced liver cirrhosis * Chronic kidney disease * Treatment with hemodialysis or peritoneal dialysis * Pregnancy or breastfeeding

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Intestinal failure are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic intestinal failure Intestinal Failure short bowel syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Intestinal failure Short bowel syndrome

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Institute of Oncology Ljubljana

    RECRUITING

    Ljubljana, 1000, Slovenia

More trials for these conditions

Other studies related to the condition(s) this trial covers.